Skip to main content
European Commission logo print header

Breakthrough gene expression search engine for cost reduction and significantly increased use of open data in drug discovery.

Objetivo

Breakthrough gene expression search engine for cost reduction and significantly increased use of open data in drug discovery. We are putting the power of genetic data analytics into the cloud and providing this as an easy to access service to biologists via a search engine. The challenge today is that as the field of sequencing is developing at a rapid pace and the amount of genetic data is exploding, nobody really can analyze all that data and pull it up when needed for making informed decision in the field of drug development and life science research. We are seizing this business opportunity through our competitive edge by creating an easily usable cloud-based gene expression search engine on top of publicly available datasets that have been analyzed and indexed by our advanced algorithms. This allows for providing unexpected discoveries in the field of drug discovery at a significantly reduced rate and insight, which has not been possible before. 

Convocatoria de propuestas

H2020-SMEInst-2014-2015

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-SMEINST-1-2014

Régimen de financiación

SME-1 - SME instrument phase 1

Coordinador

MEDICAL TECHNOLOGY GROUP OU
Aportación neta de la UEn
€ 50 000,00
Dirección
Ravala 8
10143 Tallinn
Estonia

Ver en el mapa

Pyme

Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.

Región
Eesti Eesti Põhja-Eesti
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
€ 71 429,00